In order to optimize anti-cancer activity viruses are engineered to express various immuno-stimulatory transgenes, most prominently T cell and DC activating cytokines like interleukin-2 (IL-2), interleukin-15 (IL-15) or GM-CSF91. The gene discussed is IL15; the disease is cancer.